These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 789266)

  • 1. Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours.
    Brühl P; Günther U; Hoefer-Janker H; Hüls W; Scheef W; Vahlensieck W
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):29-39. PubMed ID: 789266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
    Schnitker J; Brock N; Burkert H; Fichtner E
    Arzneimittelforschung; 1976; 26(10):1783-92. PubMed ID: 798586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of ifosfamide toxicity using dose fractionation.
    Rodriguez V; Bodey GP; Freireich EJ; McCredie KB; McKelvey EM; Tashima CK
    Cancer Res; 1976 Aug; 36(8):2945-8. PubMed ID: 1277203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced malignancies with ifosfamide under protection with mesna.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Int J Clin Pharmacol Res; 1988; 8(1):55-67. PubMed ID: 3130316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide.
    Yakushiji M; Tsunawaki A; Nishida T; Nishimura H; Natsuaki Y; Inoue T; Kato T
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1071-6. PubMed ID: 7304132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with fractionate massive-dose Ifosfamid therapy of generalized malignant tumors].
    Hoefer-Janker H; Scheef W; Günther U; Hüls W
    Med Welt; 1975 May; 26(20):972-9. PubMed ID: 1094226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies of ifosfamide for gynecological malignancies].
    Kohno I; Kazuta M; Miyao J; Kunimi N; Kawamoto M; Tanimura T; Fujiwara K; Sekiba K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1278-84. PubMed ID: 6870299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with the cytostatic drug ifosfamide].
    Ritter S; Schröder HJ
    Med Welt; 1977 Sep; 28(35):1395-1400. PubMed ID: 70737
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of pain caused by metastases of reactivated prostatic cancer with ifosfamide].
    Kawai T; Takeda T; Kihara K; Sakuramoto T; Satomi Y
    Gan No Rinsho; 1983 Aug; 29(10):1085-91. PubMed ID: 6632195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma].
    Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Kanda Y; Yamato A; Terashi K; Suda Y
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):569-72. PubMed ID: 9087289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide treatment of advanced ovarian cancer.
    Yazigi R; Wild R; Madrid J; Arraztoa J
    Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of ifosfamide in children with malignant solid tumors.
    Pratt CB; Horowitz ME; Meyer WH; Etcubanas E; Thompson EI; Douglass EC; Wilimas JA; Hayes FA; Green AA
    Cancer Treat Rep; 1987 Feb; 71(2):131-5. PubMed ID: 3100034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Palackdharry CS
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ifosfamide in advanced osteosarcoma.
    Marti C; Kroner T; Remagen W; Berchtold W; Cserhati M; Varini M
    Cancer Treat Rep; 1985 Jan; 69(1):115-7. PubMed ID: 3855382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
    Hartwich G; Neidhardt B; Lutz H
    Med Klin; 1978 Sep; 73(36):1247-52. PubMed ID: 692477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.